Professor Philip Beart (Neurodegeneration)

PhD, ANU, DSc Melbourne

Professor Beart Philip Beart has been a NH&MRC Research Fellow for 30 yrs and is currently Professorial Fellow in the Florey Institute of Neuroscience and Mental Health and Adjunct Professor in Pharmacology, University of Melbourne. He worked at the Cambridge and Harvard Universities, before holding positions at the Austin Hospital and Monash University.

Professor Graeme Jackson (Epilepsy)


Prof Graeme Jackson is the founding Director of the Brain Research Institute and a Neurologist at the Austin Hospital. He receives international recognition for his work in new MRI technologies, particularly in the field of epilepsy. He is a Professorial Fellow of the Department of Medicine and Adjunct Professor in the Department of Radiology, University of Melbourne; an Honorary Neurologist at the Royal Children’s Hospital in Melbourne and a Board member of Neurosciences Victoria. Professor Jackson recently won a highly prestigious 2008 NHMRC Excellence Award.

Professor Steven Petrou (Epilepsy)

BSci (Hons) PhD

Professor Petrou is Deputy Director and Head of the the Florey Institute of Neuroscience and Mental Health Division of Epilepsy, and heads the Laboratory of Ion Channels and Human Disease, a multidisciplinary team of researchers with a focus on revealing fundamental mechanisms of disease genesis in the central nervous system. Current major areas of investigation centre on the development and characterisation of genetically engineered mice models for the study of human familial epilepsy. He works closely with industry and has several patents for his discoveries. In addition to his many roles within the Florey Neuroscience Institutes and the University of Melbourne, he serves on the editorial board of the Journal Neurobiology of Disease and the Investigators Workshop Committee for the American Epilepsy Society.

Professor Julie Bernhardt (Stroke)

BSc, MSc, PhD

Julie is the Head of the Stroke Division and Leader of the AVERT Early Intervention Research Program. She is a Senior Principal Research Fellow and clinician researcher. Working in a large multidisciplinary team of researchers, the focus of Julie’s group is the development and testing of new exercise and rehabilitation interventions that aim to reduce the burden of stroke related disability. Julie is Australia’s leading stroke rehabilitation trialist, recently completing the largest, international trial of early mobility based rehabilitation ever conducted (AVERT), which included over 2000 patients from five countries.

Julie is also Director of the NHMRC Centre of Research Excellence in Stroke Rehabilitation and Recovery that outlines an interdisciplinary program of work from bench (discovery) to bedside (implementation). This program aims to transform how we do stroke recovery research in Australia. Julie is also committed to improving the retention of women in science and she founded the Women in Science Parkville Precinct collective impact initiative.


Professor Alan Connelly (Imaging)


Until August 2005, Alan Connelly was a Professor of Biophysics at University College London, with a particular interest in the development of magnetic resonance techniques and their application to significant clinical and neuroscientific problems. He then relocated with his research group to the Florey Institute of Neuroscience and Mental Health, where he has been instrumental in setting up new MR facilities at the Austin Campus. His work has covered a range of MR methods, with current focus primarily on diffusion and perfusion MRI and their application to the investigation of epilepsy, stroke, and cognitive function. Professor Connelly has published widely in magnetic resonance, general scientific, and neuroscientific journals.

Professor Andrew Lawrence (Behavioural Neuroscience)

BSc (Hons) PhD (Loughborough)

Professor Lawrence is a Professorial Research Fellow within the Behavioural Neuroscience division at the Florey Institute of Neuroscience and Mental Health , and head of the Addiction Neuroscience laboratory. His primary research interest is in the development of robust animal models of drug-seeking, drug-taking and drug-induced neural adaptation. In addition, his group uses these models to define new potential therapeutic targets for drug and alcohol abuse disorders. He has published over 150 original articles and reviews. Andrew Lawrence is currently Senior Editor of The British Journal of Pharmacology and also sits on the editorial boards of Neurochemical Research & Addiction Biology. In 2009, Professor Lawrence was awarded the Australian Neuroscience Society medallion for services to the society. In his spare time, Andrew is a keen cyclist and a surf life guard.

Associate Professor Amy Brodtmann (Behavioural Neuroscience)


A/Prof Brodtmann is a Senior Postdoctoral Research Fellow, as well as holding joint appointments as a neurologist at Austin Health and Box Hill Hospital.

Her research focuses on novel uses of fMRI in patients with cerebrovascular disease, correlating signal changes with perfusion data and clinical parameters. Other interests are in the neural basis of neglect, and the diagnosis of focal onset dementias.

She is a current recipient of a NHMRC Training Research Fellowship, and was recently appointed as the National Brain School Co-ordinator, overseeing post-graduate education for neurology trainees.

Professor Trevor Kilpatrick (Multiple Sclerosis)


Trevor Kilpatrick leads the MS Division at the Florey and is a neurologist and Head of the MS Unit at the Royal Melbourne Hospital, in addition to being Director of the Centre for Neuroscience at The University of Melbourne. His research interests include the neurobiology of multiple sclerosis, neural precursor cell biology and the study of genetic and environmental factors that contribute to MS as well as the translation of basic research discoveries to the clinic.

Professor Kilpatrick has been the recipient of the Sunderland Award, AMRAD Postdoctoral Award and the inaugural Leonard Cox Award. More recently, Professor Kilpatrick and his Group were awarded the Australian Museum’s Jamie Callachor Eureka Prize for Medical Research (2008) in recognition of their extraordinary contribution to medical research into multiple sclerosis.

Professor Seong-Seng Tan (Brain Development & Regeneration)

BDS (Mal) MDS (Adel)  DPhil (Oxon) FRACDS

Professor Tan is NH&MRC Senior Principal Research Fellow, and Adjunct Professor at The University of Melbourne Centre for Neuroscience, and University of Queensland Brain Institute.  He is interested in understanding how the brain is assembled during development, and what mechanisms protect brain cells from death following brain injury such as trauma and stroke.  Professor Tan has published over 100 papers and was awarded the Amgen Australia Medical Research Award (1997).  He is on the Editorial Boards of the Journal of Neuroscience (USA) and Experimental Neurology.  Professor Tan is a keen swimmer and a member of the Brighton Iceburgers.

Professor Robin McAllen (Systems Neurophysiology)


Professor Robin McAllen is a NHMRC Principal Research Fellow. He trained in Physiology in London and Birmingham and in Medicine at Birmingham (UK) before moving to the Florey in 1988. He is a neurophysiologist with an interest in the central nervous regulation of cardiovascular and autonomic functions, and has published extensively of this topic. More recently he has collaborated with the Florey Institute of Neuroscience and Mental Health colleagues in neuroimaging experiments that aim to translate lessons learned from animal studies to the human brain. He currently serves on the   editorial board of the American Journal of Physiology, is a section editor for Clinical and Experimental Pharmacology and Physiology, and is a member of the Faculty of 1000.

Professor Richard Macdonell (Systems Neurophysiology)


Professor Richard Macdonell is Director of Neurology at Austin Health and an Honorary Professorial Fellow at the Florey Institute of Neuroscience and Mental Health. He trained in Neurology and Clinical Neurophysiology at Austin Health, Massachusetts General and the London Hospitals and has been in charge of the Neurophysiology and Neuroimmunology services at Austin Health since 1991. His research interests include multiple sclerosis, peripheral nerve and muscle disorders and using transcranial magnetic stimulation to study the pathophysiology of epilepsy.

A/Professor Ross Bathgate (Neuropeptides)

BSc (Hons) PhD

Associate Professor Ross Bathgate is a NHMRC Senior Research Fellow (Level B) and an Honorary Principle Research Fellow in the Department of Biochemistry and Molecular Biology at The University of Melbourne. His work focuses on the relaxin family of peptides and their G-protein coupled receptors. He has published over 200 papers including numerous invited reviews on relaxin peptides and their receptors, with a total of over 5800 career citations and a h-index of 41. His work has attracted substantial funding from the NHMRC and other Australian funding bodies as well as pharmaceutical companies.

Professor Colin L Masters MD

Professor Masters is the Head of the Mental Health Division at the Florey and a Laureate Professor at the University of Melbourne. He is also the Senior Deputy Director of the Florey Institute of Neuroscience and Mental Health, and a consultant at the Royal Melbourne Hospital. His achievements have been recognised by the receipt of many international awards - including the Potamkin Prize (1990), the Max Plank Research Award (1992), the Zülch Prize (1995), the King Faisal Prize (1996), the Alois Alzheimer Award (1998), the Lennox K Black Prize (2006), the Grand Hamdan Award (2006) and the Victoria Prize (2007), CSIRO Medal for Research Achievement (2011).